Copy

SWI Ratings Report - April 1, 2015

SWI QuickPicks Ratings Report

April 1, 2015

 

Stocks have been on a wild ride again, driven by wild speculations and more or less intelligent interpretations of what the Feds are actually saying; some suspecting that they may be "wagging the tail" in reaction to certain global market events and conditions, instead of giving solid guidance for the future of our economy. You ask five analysts and you get ten different opinions. So instead, we simply publish our next report and show you the adjustments that we have made for past picks and our "guidance" for the future, meaning that several new picks we are suggesting may deserve your attention and due diligence.   
                    
We have begun SWI Analyst coverage on two NASDAQ biotech stocks (NeoStem (NBS) and Cellular Biomedicine Group (CBMG) and will be commencing with coverage on another OTC biotech company soon. All three firms are involved in the research and development of technologies for the treatment of autoimmune diseases and a variety of hard to treat cancers. Please visit www.stockwatchindex.com/stock-watch-index for more detail on those stocks. 

Having conducted extensive research in this area, we felt comfortable adding a biopharmaceutical company , "Cara Therapeutics, Inc." (CARA:NASDAQGM) and another biotechnology company "Harvard Apparatus Regenerative Technology, Inc." (HART:NASDAQCM) to our QuickPicks for your review. The third company we added, "Advantage Oil & Gas Limited", (AAV:NYSE) has shown strong financial performance within a badly beaten down sector that is poised to rise again; you pick the bottom.
 

Remember, in addition to our own research for our QuickPicks section, we pour over charts and third party analyst opinions and reports from such firms and individuals that we respect, in order to reach as much of a consensus as you might be able to reach during these wild market movements . Naturally, on occasion the investment thesis for certain picks may break down. When that happens, we let you know as quickly as possible. Again, don't rely only on our guidance, but do your own due diligence and stick to your trading plan.
 

 
Please try out our new service www.swiresearch.com. We would appreciate if you could please pass this on to your friends and colleagues and we always appreciate your feedback and comments.
 
About SWI
SWI is a leading-edge PR, Information Marketing and Research Service with a highly frequented web site www.stockwatchindex.com, its "Rise Above The Noise" newsletter and SWI Research  site www.swiresearch.com. These services provide you with information and research on new and promising public companies. The QuickPicks section on the SWI site represents the consolidated opinions of carefully selected financial analyst blogs and opinions of leading Wall Street firms that we respect and frequently sample. The weekly SWI QuickPicks  Ratings Report keeps you informed about newly initiated stocks and potential upgrades and downgrades by us in our QuickPicks section. We are not being compensated by these companies and do not necessarily hold positions in any one of these stocks.  You can conveniently follow the live links for each of these stocks on http://www.stockwatchindex.com/swi-quickpicks for more detail.  SWI's periodical "Portfolio Performance Report" frequently updates the performance of the stocks that we have purchased and are holding in the SWI Portfolio, as published on our WatchIndex page. Please do not miss the wealth of frequently updated news, research reports, financial white papers and other valuable information elsewhere on SWI. Watch a full range of CEO and analyst interviews on our Strategic Partner site www.wideworldofstocks.com.  
 
Facebook
Twitter
LinkedIn
Google +
StockWatchIndex
 
Good luck and please pass this newsletter on to a friend
to continue building our community.
 

StockWatchIndex (SWI) is not a registered investment adviser and makes no warranty, expressed or implied, as to the accuracy, or completeness, or fitness for a purpose (investment or otherwise) of the information provided in the publications of its Newsletter, Stock Watch List or on its web sites. The provided information is not to be construed as personal financial advice, or a solicitation to buy or sell stock. Some information has been generated by what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or  warrant any results from use of the information. We have contracted with some of the companies we present on SWI as public relations consultants to keep the market and especially our subscribers informed about the companies. We may have been compensated in cash and/or stock and stock options, which may be considered a potential conflict of interest. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in its newsletter or on its web sites. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. StockWatchIndex expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. The included information is subject to change without notice.

Copyright © 2015 DynamicMarketConcepts, All rights reserved.


unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp